KIDNEY TRANSPLANTATION FROM DECEASED DONORS: GRAFT AND PATIENT SURVIVAL RATES

Trọng Hiền Nguyễn1,, Minh Sâm Thái1,2, Ngọc Sinh Trần1,2
1 Cho Ray Hospital,
2 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: Deceased donors (DD) help expand the organ donation pool and are becoming a global trend in transplantation as the supply from living donors is insufficient to meet the demand. Research Objectives: To present the graft survival rate, patient survival rate, and factors influencing these survival rates. Research Methods: This is a retrospective, descriptive cohort study, which included cases that received kidneys from DDs from April 2008 to December 2021 at Cho Ray Hospital.  Results and discussion: The study included 27 DDs with a median age of 37, with males making up 88.8%. The median KDPI (Kidney Donor Profile Index) was 35%. There were 51 kidney recipients, with a median age of 37, 72.5% males, a body mass index of 20.9, a median dialysis duration of 39.3 months, with hemodialysis being the predominant treatment method. The median cold ischemia time was 7 hours and the warm ischemia time was 38 minutes. The main induction immunosuppressant drugs were IL-2 receptor inhibitors, constituting 64.7%, and the main maintenance immunosuppressant was tacrolimus (94.1%). The graft survival rates at 1-year, 3-years, and 5-years were sequentially 100%, 97.7%, and 95.1%. The patient survival rates at these intervals were 96.1%, 93.6%, and 93.6%. Significant factors affecting graft survival included: donor age over 60, KDPI over 80%, delayed graft function, acute rejection in the first year, and estimated glomerular filtration rate lower than 45 ml/min/1.73m2 at one-month post-transplant. Significant factors affecting patient survival were: DD meeting the circulatory death criteria, recipients under 40 and 50 years of age, and delayed graft function. Conclusion: The study indicates that the graft and patient survival rates are comparable to international figures. Thus, using kidneys from DDs is feasible. However, given the limited sample size in the study, further research with a larger number of recipients is recommended.

Article Details

References

Watson C, Dark J. Organ transplantation: historical perspective and current practice. British journal of anaesthesia. 2012;108(suppl_1):i29-i42.
2. Martin DE, Van Assche K, Domínguez-Gil B, et al. Strengthening Global Efforts to Combat Organ Trafficking and Transplant Tourism: Implications of the 2018 Edition of the Declaration of Istanbul. Transplantation Direct. 2019;5(3):e433. doi:10.1097/txd.0000000000000872
3. Kute V, Ramesh V, Shroff S, Guleria S, Prakash J. Deceased-donor organ transplantation in India: current status, challenges, and solutions. Exp Clin Transplant. 2020;18(Suppl 2):31-42.
4. Summers DM, Watson CJE, Pettigrew GJ, et al. Kidney donation after circulatory death (DCD): state of the art. Kidney International. 2015;88(2):241-249. doi:10.1038/ki.2015.88
5. Chen G, Wang C, Ko DSC, et al. Comparison of outcomes of kidney transplantation from donation after brain death, donation after circulatory death, and donation after brain death followed by circulatory death donors. Clinical transplantation. 2017;31(11):e13110.
6. Aida N, Ito T, Kurihara K, Naka Mieno M, Nakagawa Y, Kenmochi T. Analysis of risk factors for donation after circulatory death kidney transplantation in Japan. Clinical and Experimental Nephrology. 2022;26(1):86-94.
7. Summers DM, Johnson RJ, Hudson A, Collett D, Watson CJ, Bradley JA. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. The Lancet. 2013/03/02/ 2013;381(9868):727-734. doi: https:// doi.org/10.1016/S0140-6736(12)61685-7
8. Vũ LN. Đánh giá kết quả của lấy, rửa và ghép thận từ người chết não tại bệnh viện Việt Đức. Trường Đại Học Y Hà Nội; 2014.
9. Vũ LN, Tuấn TM, Cường NT, et al. Ghép thận từ người cho chết não tại bệnh viện Việt Đức giai đoạn 2010-2020. Y Học Việt Nam. 2021; 509 (Tháng 12 - số chuyên đề)(Công trình nghiên cứu khoa học lần thứ XV hội Tiết Niệu - Thận Học Việt Nam; lần thứ VII VUNA - North, 2021): 419 - 427.
10. Roman J, Jalůvka F, Ostruszka P, et al. Post-Kidney Transplantation Results After Circulatory or Brain Death Without Pre-Mortem Heparin Administration. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2022;28:e936877-1.